Iván Hancco-Zirena

Dr. Iván Hancco-Zirena

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
SDStéphane Doutreleau
Stéphane Doutreleau
MUMathilde Ulliel-Roche
Mathilde Ulliel-Roche
IHIván Hancco-Zirena
Iván Hancco-Zirena
Sébastien BaillySébastien Bailly
Sébastien Bailly
LOLaura Oberholzer
Laura Oberholzer
SVSamuel Verges
Samuel Verges
A unique Andean population lives in the highest city of the world (La Rinconada, 5100 m, Peru) and frequently develops a maladaptive syndrome, termed chronic mountain sickness (CMS). Both extreme altitude and CMS are a challenge for the cardiovascular system. This study aims to evaluate cardiac remodelling and pulmonary circulation at rest and during exercise in healthy and CMS highlanders. Highlanders living permanently at 3800 m (n = 23) and 5100 m (n = 55) with (n = 38) or without CMS (n = 17) were compared with 18 healthy lowlanders. Rest and exercise echocardiography were performed to describe cardiac remodelling, pulmonary artery pressure (PAP), and pulmonary vascular resistance (PVR). Total blood volume (BV) and haemoglobin mass were determined in all people. With the increase in the altitude of residency, the right heart dilated with an impairment in right ventricle systolic function, while the left heart exhibited a progressive concentric remodelling with Grade I diastolic dysfunction but without systolic dysfunction. Those modifications were greater in moderate–severe CMS patients. The mean PAP was higher both at rest and during exercise in healthy highlanders at 5100 m. The moderate–severe CMS subjects had a higher PVR at rest and a larger increase in PAP during exercise. The right heart remodelling was correlated with PAP, total BV, and SpO2. Healthy dwellers at 5100 m exhibit both right heart dilatation and left ventricle concentric remodelling with diastolic dysfunction. Those modifications are even more pronounced in moderate–severe CMS subjects and could represent the limit of the heart's adaptability before progression to heart failure.

24 October 2024 in Pulmonology
Verified
Journal Article
Open access
BCBenoit Champigneulle
Benoit Champigneulle
ESEmeric STAUFFER
Emeric STAUFFER
PRP. Robach
P. Robach
SDS. Doutreleau
S. Doutreleau
CHC.A. Howe
C.A. Howe
SVS. Verges
S. Verges
Chronic Mountain Sickness (CMS) syndrome, combining excessive erythrocytosis and clinical symptoms in highlanders, remains a public health concern in high-altitude areas, especially in the Andes, with limited therapeutic approaches. The objectives of this study were to assess in CMS-highlanders permanently living in La Rinconada (5100-5300 m, Peru, the highest city in the world), the early efficacy of acetazolamide (ACZ) and atorvastatin to reduce hematocrit (Hct), as well as the underlying mechanisms focusing on intravascular volumes. Forty-one males (46±8 years of age) permanently living in La Rinconada for 15 [10-20] years and suffering from CMS were randomized between ACZ (250 mg once-daily; N = 13), atorvastatin (20 mg once-daily; N = 14) or placebo (N = 14) uptake in a double-blinded parallel study. Hematocrit (primary endpoint) as well as arterial blood gasses, total hemoglobin mass (Hbmass) and intravascular volumes were assessed at baseline and after a mean (±SD) treatment duration of 19±2 days. ACZ increased PaO2 by +13.4% (95% CI: 4.3 to 22.5%) and decreased Hct by -5.2% (95% CI: -8.3 to -2.2%), whereas Hct remained unchanged with placebo or atorvastatin. ACZ tended to decrease Hbmass (-2.6%, 95% CI: -5.7 to 0.5%), decreased total red blood cell volume (RBCV, -5.3%, 95% CI: -10.3 to -0.3%) and increased plasma volume (PV, +17.6%, 95% CI: 4.9 to 30.3%). Atorvastatin had no effect on intravascular volumes, while Hbmass and RBCV increased in the placebo group (+6.1%, 95% CI: 4.2 to 7.9% and +7.0%, 95%CI: 2.7 to 11.4%, respectively). Short-term ACZ uptake was effective to reduce Hct in CMS-highlanders living at extreme altitude >5,000 m and was associated with both an increase in PV and a reduction in RBCV.

15 April 2024 in American Journal of Hematology
Verified
Journal Article
Open access
ESEmeric Stauffer
Emeric Stauffer
APAurélien P. Pichon
Aurélien P. Pichon
BCBenoit Champigneulle
Benoit Champigneulle
MFMichaël Furian
Michaël Furian
IHIván Hancco-Zirena
Iván Hancco-Zirena
Lars KaestnerLars Kaestner
Lars Kaestner
We investigated highlanders, permanently living at an altitude of 5100 m and compared Chronic Mountain Sickness (CMS) patients with control volunteers. While we found differences in systemic parameters such as blood oxygen content, hematocrit, hemoglobin concentration, and blood viscosity, the mechanical and rheological properties of single red blood cells did not differ between the two investigated groups.

30 December 2020 in ACTA MEDICA PERUANA
Verified
Journal Article
Open access
PDF file
MQMariela M. Quispe-Trujillo
Mariela M. Quispe-Trujillo
JTJeancarlo Tejada-Flores
Jeancarlo Tejada-Flores
DODavid Ochoa-Torres
David Ochoa-Torres
KMKevin O. Morales-Pocco
Kevin O. Morales-Pocco
SCSamir Colquehuanca-Chuquija
Samir Colquehuanca-Chuquija
IHIván Hancco-Zirena
Iván Hancco-Zirena
Objetivo: describir la función cardiovascular y determinar las alteraciones cardiacas en pacientes con y sin eritrocitosis excesiva (EE). Materiales y métodos: estudio de tipo prospectivo, transversal y analítico. La muestra fue de 61 pacientes residentes del Centro Poblado La Rinconada, localizado en Puno – Perú, ubicado a 5 200 m.s.n.m. Se utilizó una ficha de recolección de datos, se aplicó el score de mal de montaña crónico de Qinghai y un cardiólogo experimentado realizo las ecocardiografías. Resultados: el promedio de edad fue de 44 ± 7 años y el tiempo de residencia fue de 16 ± 9,8 años. Del total de pacientes, el 80,3% presentó mal de montaña crónico; de estos, el 68,9% fue de grado leve, 6,6% de grado moderado y el 4,9% de grado severo. Dentro de los hallazgos ecocardiográficos se encontraron: dilatación de cavidades cardiacas (16,4%), leve alteración del llenado del ventrículo derecho (3,27%), válvula aórtica bicúspide (3,27%), dificultad del llenado del ventrículo izquierdo (8,2%), leve alteración en la relajación y llenado del ventrículo izquierdo (1,6%), insuficiencia aórtica leve (1,6%) e hipertensión pulmonar (1,6%). El 83,6% presentaba hemoglobina ≥ 21 mg/dl. Conclusiones: el grupo con EE presentó más alteraciones cardiacas, la alteración cardiaca más frecuente fue la dilatación de cavidades cardiacas derechas.

9 April 2024 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
KVKely Melina Vilca-Coaquira
Kely Melina Vilca-Coaquira
RCRossela Alejandra Rojas Chambilla
Rossela Alejandra Rojas Chambilla
JFJeancarlo Tejada Flores
Jeancarlo Tejada Flores
HRHenry Oscar Tintaya Ramos
Henry Oscar Tintaya Ramos
MTMariela Mercedes Quispe Trujillo
Mariela Mercedes Quispe Trujillo
IHIván Hancco-Zirena
Iván Hancco-Zirena
Background: Previous studies showed that residents of higher elevations have lower glucose levels. Our objective in this study is to determine the basal and postprandial glucose levels in apparently healthy permanent residents of the miner population center of La Rinconada located 5100 meters (m) above sea level.Method: Forty male permanent residents of the Rinconada miner population center were studied. The oral glucose tolerance test was used to evaluate basal and postprandial glycemia levels at 1, 2, and 3 h.Results: The individuals had a mean age of 43.95 ± 8.54 years. Basal glycemia in subjects without excessive erythrocytosis (EE) was 73.3 ± 7.9 mg/dL, while levels in patients with EE were 57.98 ± 7.38 mg/dL. In the postprandial period, at 1 h after oral glucose overload, a mean value of 76.35 ± 13.53 mg/dL was observed in subjects with EE compared to 94.68 ± 9.98 mg/dL in subjects without EE. After 2 h, subjects with EE had a glycemia level of 72.91 ± 9.17 mg/dL EE compared to 90.73 ± 13.86 mg/dL without EE. At 3 h, the average glycemia level in subjects with EE was 70.77 ± 8.73 mg/dL compared to 87.79 ± 14.16 mg/dL in those without EE.Conclusion: These findings suggest that under hypoxic conditions, glycemia levels are lower in both subjects with and without EE, having obtained lower levels in subjects with EE in relation to those with normal values of Hb and Hct. The results of this study indicate that in the conditions of severe hypoxia, blood glucose levels are below the values considered normal for sea level.

13 January 2025 in Oxygen
Verified
Journal Article
Open access
PDF file
KVKely Melina Vilca-Coaquira
Kely Melina Vilca-Coaquira
AHAngel Gabriel Calisaya Huacasi
Angel Gabriel Calisaya Huacasi
JTJeancarlo Tejada-Flores
Jeancarlo Tejada-Flores
HTHenry Oscar Tintaya-Ramos
Henry Oscar Tintaya-Ramos
MQMariela Mercedes Quispe-Trujillo
Mariela Mercedes Quispe-Trujillo
IHIván Hancco-Zirena
Iván Hancco-Zirena
Previous studies indicate that individuals at high altitudes have a lower pain threshold than those living at sea level. This study evaluates the differences in pain perception among young people living at an altitude of 3800 m and after acute exposure to a severe hypoxic environment at more than 5100 m. Fourteen people (BMI of 22.6 ± 1.2 and age of 23.3 ± 1.9 years) residing in the city of Puno (3825 m) participated in an ascent to the Populated Center of La Rinconada (>5100 m). The unilateral ischemia pain provocation test was used, applying pressure with a manual sphygmomanometer to generate transient ischemia in the arm while the patient opens and closes their hand. Onset, peak, and resolution times of pain, heart rate, and oxygen saturation were recorded. At their residence altitude of 3828 m, the mean hemoglobin was 16.16 ± 2.29, while at 5100 m, mean hemoglobin increased to 17.57 ± 1.74. The average time to pain onset in the right arm was 30.43 s ± 14.15 at 3828 m, whereas at 5100 m above sea level, the pain perception was at 31.00 s ± 19.01. At 3828 m, the average time until pain sensation in the left arm was 19.93 s ± 9.44 and increased to 23.07 s ± 10.83 at 5100 m. During exposure to a severe hypoxic environment, the pain perception threshold was similar between 3828 m and 5100 m above sea level.